COMMUNIQUÉS West-GlobeNewswire

Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference
15/10/2026
CAMBRIDGE, Mass., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on advancing next-generation medicines in immunology and inflammation, [...]
Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026
15/10/2026
SALT LAKE CITY, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its third quarter 2026 earnings conference call at 4: [...]
LB Pharmaceuticals to Participate in Upcoming Investor Events
15/10/2026
NEW YORK, Oct. 15, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that [...]
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
15/10/2026
CONSHOHOCKEN, Pa., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated [...]
MacroGenics Announces First Patient Dosed in Phase 1 Study of MGC030 in Patients with Advanced Solid Tumors
15/10/2026
ROCKVILLE, MD, Oct. 15, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, [...]
Full 12-Month Data from the ACCCESS U.S. Pivotal Study in Complete Concentric Collapse Patients Presented at ISSS 2026
15/10/2026
Full 12-Month Data from the ACCCESS U.S. Pivotal Study in Complete Concentric Collapse Patients Presented at ISSS 2026 Genio® bilateral stimulation delivered a 74.3% median reduction in AHI at 12 months, with no device [...]
Données Complètes à 12 Mois de l’Étude Pivot Américaine ACCCESS chez les Patients Atteints de Collapsus Concentrique Complet Présentées à l’ISSS 2026
15/10/2026
Données Complètes à 12 Mois de l’Étude Pivot Américaine ACCCESS chez les Patients Atteints de Collapsus Concentrique Complet Présentées à l’ISSS 2026 La stimulation bilatérale Genio® a permis une réduction médiane de 74 [...]
Syndax’s Revuforj® (revumenib) Named to TIME’s Best Inventions of 2026 List
15/10/2026
NEW YORK, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Revuforj ® (revumenib), the [...]
Opus Genetics Presents Positive Clinical Data from OPGx-BEST1 and OPGx-LCA5 Gene Therapy Programs at Retina in Rio 2026
15/10/2026
OPGx-BEST1 showed improved retinal sensitivity in 75% of evaluable participants in the initial low-dose Cohort 1 of the Company’s Phase 1/2 clinical trial, supporting further clinical development New BEST1 data analyses [...]
MDxHealth Announces Preliminary Third Quarter 2026 Revenue and Suspends Full-Year 2026 Revenue Guidance
15/10/2026
IRVINE, CA – October 15, 2026 ( GlobeNewswire ) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leader in urology-focused precision diagnostics, today announced preliminary unaudited revenue from [...]
Anavex Receives FDA Clearance of its IND Application for Blarcamesine in Fragile X Syndrome
15/10/2026
Anavex now has open INDs in all three core indications: Alzheimer's disease, Rett syndrome, and Fragile X syndrome Phase 2a study will evaluate the safety, tolerability and pharmacokinetics of blarcamesine oral solution [...]
Avance Clinical to Showcase its Early Phase Center of Excellence Model at AusBiotech International 2026
15/10/2026
Australian-headquartered global CRO with more than 30 years of early phase experience to meet sponsors at Stand #72, Gold Coast, 21–23 October 2026 ADELAIDE, Australia, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Avance Clinical [...]
Digbi Health Brings Precision Biology Care to All 50 States With 700+ Clinicians and Coaches Through OpenLoop Health and MD Integrations
15/10/2026
More than 300 employers and health plans now offer a unified platform for metabolic, inflammatory, and hormonal care, built on each member’s gut microbiome, genetics, and glucose data, as a fully covered benefit [...]
Booking Health Announces Medical Records Review, Specialist Second Opinions and Treatment Coordination for Pancreatic Cancer Patients Seeking Care in Germany
15/10/2026
Langenfeld, Germany --, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Booking Health, a medical travel coordination service, announces medical records review, specialist second opinions and full treatment coordination for [...]
Spineway : NINE-MONTH REVENUE
15/10/2026
Press release / Ecully, October 15, 2026 – 6 p.m. NINE-MONTH REVENUE: €8 MILLION Continued structuring to optimize supply and support the growth strategy Appointment of Erwan Martin as Deputy Chief Executive Officer In [...]
SPINEWAY : CHIFFRE D’AFFAIRES À 9 MOIS
15/10/2026
Communiqué de presse / Ecully, le 15 octobre 2026 – 18h CHIFFRE D’AFFAIRES 9 MOIS : 8 M€ Poursuite de la structuration pour optimiser les approvisionnements et contribuer à la stratégie de développement Nomination d’ [...]
VIP Plastic Surgery Designated an Accredited Medical Tourism Institution by South Korea’s Ministry of Justice
15/10/2026
Jeju clinic becomes one of two institutions on the island able to sponsor electronic medical visas for 2026-27 JEJU, South Korea, Oct. 15, 2026 (GLOBE NEWSWIRE) -- VIP Plastic Surgery , a Jeju clinic, has been [...]
Oxford Healthspan Launches Primeadine® GF Spermidine Powder, Expanding Its Gluten-Free Line
15/10/2026
New Mixable Gluten-Free Format Offers a More Flexible Way to Incorporate Spermidine Daily SHERIDAN, Wyo., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Oxford Healthspan today announced the launch of Primeadine® GF Spermidine [...]
Affidea signe un accord en vue d’acquérir deux centres Alliance Medical dans le centre de Londres, accélérant ainsi sa croissance au Royaume-Uni
15/10/2026
LONDRES, 15 oct. 2026 (GLOBE NEWSWIRE) -- Affidea , un prestataire paneuropéen de premier plan, spécialisé dans les cliniques de proximité, les examens diagnostiques de pointe et les services de santé privés spécialisés [...]

Pages